276 related articles for article (PubMed ID: 28746261)
1. Rotavirus Infection in the Auckland Region After the Implementation of Universal Infant Rotavirus Vaccination: Impact on Hospitalizations and Laboratory Implications.
McAuliffe GN; Taylor SL; Drinković D; Roberts SA; Wilson EM; Best EJ
Pediatr Infect Dis J; 2018 Jan; 37(1):e1-e5. PubMed ID: 28746261
[TBL] [Abstract][Full Text] [Related]
2. Hospitalised rotavirus gastroenteritis in New Zealand: The laboratory database is a valuable tool for assessing the impact of rotavirus vaccination.
Kelly MJ; Foley D; Blackmore TK
Vaccine; 2017 Aug; 35(35 Pt B):4578-4582. PubMed ID: 28720280
[TBL] [Abstract][Full Text] [Related]
3. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
[TBL] [Abstract][Full Text] [Related]
4. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis.
Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E
Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322
[TBL] [Abstract][Full Text] [Related]
5. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
[TBL] [Abstract][Full Text] [Related]
6. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
[TBL] [Abstract][Full Text] [Related]
7. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
Tsolenyanu E; Djadou KE; Fiawoo M; Akolly DAE; Mwenda JM; Leshem E; Tate JE; Aliabadi N; Koudema W; Guedenon KM; Godonou M; Dagnra A; Gbadoe AD; Boko A; Landoh D; Atakouma Y; Parashar UD
Vaccine; 2018 Nov; 36(47):7185-7191. PubMed ID: 29397224
[TBL] [Abstract][Full Text] [Related]
8. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
9. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
[TBL] [Abstract][Full Text] [Related]
10. Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.
Tsolenyanu E; Mwenda JM; Dagnra A; Leshem E; Godonou M; Nassoury I; Landoh D; Tate JE; Atakouma Y; Parashar UD
Clin Infect Dis; 2016 May; 62 Suppl 2():S196-9. PubMed ID: 27059356
[TBL] [Abstract][Full Text] [Related]
11. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil.
Fernandes EG; Sato HK; Leshem E; Flannery B; Konstantyner TC; Veras MA; Patel MM
Vaccine; 2014 Jun; 32(27):3402-8. PubMed ID: 24736002
[TBL] [Abstract][Full Text] [Related]
12. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
[TBL] [Abstract][Full Text] [Related]
13. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
[TBL] [Abstract][Full Text] [Related]
14. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
[TBL] [Abstract][Full Text] [Related]
15. Impact of rotavirus vaccination on child mortality, morbidity, and rotavirus-related hospitalizations in Bolivia.
Inchauste L; Patzi M; Halvorsen K; Solano S; Montesano R; Iñiguez V
Int J Infect Dis; 2017 Aug; 61():79-88. PubMed ID: 28627429
[TBL] [Abstract][Full Text] [Related]
16. Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5 years of age, Ghana, 2009-2016.
Enweronu-Laryea CC; Armah G; Sagoe KW; Ansong D; Addo-Yobo E; Diamenu SK; Mwenda JM; Parashar UD; Tate JE
Vaccine; 2018 Nov; 36(47):7131-7134. PubMed ID: 29752020
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.
Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J
BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824
[TBL] [Abstract][Full Text] [Related]
18. Early impact of rotavirus vaccination in children less than five years of age in Mozambique.
de Deus N; Chilaúle JJ; Cassocera M; Bambo M; Langa JS; Sitoe E; Chissaque A; Anapakala E; Sambo J; Guimarães EL; Bero DM; João ED; Cossa-Moiane I; Mwenda JM; Weldegebriel GG; Parashar UD; Tate JE
Vaccine; 2018 Nov; 36(47):7205-7209. PubMed ID: 29128381
[TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: a descriptive epidemiological study from Germany.
Pietsch C; Liebert UG
Clin Microbiol Infect; 2019 Jan; 25(1):102-106. PubMed ID: 29649603
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
